Bayer: Science For A Better Life
Contact us | RSS | Sitemap  | Dansk  | Norsk  | Svenska
 
Special Interests
16-Apr-2008
Medicinal plants receive Bayer’s Innovation Award
Protein made in genetically modified plants can help millions of elderly people under the risk of developing senility. The Danish scientist behind the development is rewarded with Innovation Award from Bayer CropScience.
 
Aarhus, April 2008. 

Lars Berglund, co-founder of the Danish biotech company Cobento A/S receives Innovation Award from Bayer CropScience for his extraction of a plantmade protein, the function of which is to bind vitamin B12 so that the vitamin can be introduced into the body.

Vitamin B12 deficiency is a problem for many elderly people around the world. Close to 30 percent of Danish people aged more than 60 years suffers from lack of vitamin B12. This amounts to around 2-300.000 people.

Humans absorb the important vitamin B12 through their diet. Reduced production of the protein ”intrinsic factor” that binds vitamin B12 to the body means less absorption of vitamin B12, causing a problem especially among the older segment of the population. Vitamin B12 deficiency may lead to irreversible damage to the nervous system and to the development of senility, depression, and Alzheimer’s disease.

Plant made medicine

Lars Berglund and his team have succeeded in producing plants that can form intrinsic factor identical to the kind found in humans. The protein is produced in the wall cress plant which is grown in greenhouses. This brings about hope for the millions of elderly people who cannot absorb sufficient amounts of vitamin B12.

A vitamin tablet with intrinsic factor from the plants ensures that the user can reestablish a natural absorption of vitamin B12. Cobento’s plantproduced protein does not only mean that disease can be prevented; the protein will also improve the possibilities of diagnosing lack of B12.
The current research has resulted in Cobento A/S being one of few companies having optained authorization to grow genetically modified plants for medicine production and who is therefore in a position to carry out the production on a commercial scale.

In this way Cobento’s first GM-plant also helps pave the way for a reorientation of a part of the horticultural and agricultural production of high-value specialty products. The horticultural trade and, in the long term, also agriculture will get the opportunity of bigger earnings by moving from traditional bulk production of low-value products to a production of high-value GM-products.

Bayer supports sustainable agriculture

Ernst v. Franck, Head of Bayer CropScience in the Nordics, explains the initiative behind the In-novation Award: - "Bayer CropScience has made a commitment to promote sustainable agricul-ture on a global scale. We, in the Nordic countries, have therefore chosen to present an annual Innovation Award in support of initiatives which contribute with innovation and sustainable initiatives within integrated and economical production, food quality and safety, plant breeding, and environmental safety.”

“This year’s Danish recipient of the Bayer CropScience Innovation Award contributes in a groundbreaking way to this development”, Ernst v. Franck maintains.

This year’s Innovation Award of Euro 10.000 is divided between this project and a Swedish research project. The Award for the Danish project will be presented today at the University of Aarhus. Carl Åge Pedersen, Head of Dansk Landbrugsrådgivning, Landscenteret (Danish Agricultural Advisory Service, National Centre), will introduce the project and Eyvind Vesselbo, MP and spokesman on environmental policy for Venstre (the Liberal Party), will present the Award.

Contact person:

Gitte Finnich Pedersen, Head of Corporate Communications Bayer Norden
Phone: + 45 45 23 50 07
E-mail: gitte.finnichpedersen.gf@bayer.dk

More information at:
www.bayer.dk
www.cobento.dk



About Bayer CropScience Innovation Award
With the award, Bayer CropScience Norden wishes to support sustainable initiatives within agriculture and food production. The award is granted people in the Nordic countries, such as students, researchers, advisors, farmers, or salesmen. In the award selection, Bayer CropScience attaches great importance to the fact that nominees contribute with inventive thinking and sustainable initiatives. They should do so through practical work or research and development within areas such as: Integrated production, food quality and food safety, plant breeding, and environmental safety.

About Bayer CropScience
Bayer CropScience is a subsidiary of Bayer AG, with an annual turnover of approximately Euro 5.8 billion. It is one of the world's leading innovative crop science companies within crop protection, seed and biotechnology, and non-agricultural-specific weed control. The company offers a unique range of products and comprehensive services for modern, sustainable agriculture and non-agriculture-related solutions. Bayer CropScience has 17,900 employees worldwide and is represented in 120 countries (2007).

In the Nordic countries, Bayer CropScience is part of Bayer Norden with Nordic headquarters in Kgs. Lyngby, Copenhagen. In 2007, Bayer Norden had a turnover of Euro 515 million of which Bayer CropScience Norden accounted for approx. Euro 80 million.

Globally, Bayer CropScience is committed to promote sustainable social developments in congruence with the definition crafted at the UN summit. Among others, through investments in industrial plants that uses the resources and leave less emmissions to the environment. This is also done through a continuous promotion of sustainable agriculture.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Print
Search

Advanced Search
Bayer Websites Worldwide
Quick Links
News Links
Bayer Share Price